1. Início
  2. Publicações
  3. Comparison of Recent Practice Guidelines for the Management of Patients With Asymptomatic Carotid Stenosis

Comparison of Recent Practice Guidelines for the Management of Patients With Asymptomatic Carotid Stenosis

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Armando Amilcar Pires Mansilha Rodrigues De Almeida

    Autor

Participantes de fora da FMUP

  • Paraskevas, KI
  • Mikhailidis, DP
  • Antignani, PL
  • Ascher, E
  • Baradaran, H
  • Bokkers, RPH
  • Cambria, RP
  • Comerota, AJ
  • Dardik, A
  • Davies, AH
  • Eckstein, HH
  • Faggioli, G
  • Fernandes, JFE
  • Fraedrich, G
  • Geroulakos, G
  • Gloviczki, P
  • Golledge, J
  • Gupta, A
  • Jezovnik, MK
  • Kakkos, SK
  • Katsiki, N
  • Knoflach, M
  • Kooi, ME
  • Lanza, G
  • Lavenson, GS
  • Liapis, CD
  • Loftus, IM
  • Millon, A
  • Nicolaides, AN
  • Pini, R
  • Poredos, P
  • Proczka, RM
  • Ricco, JB
  • Riles, TS
  • Ringleb, PA
  • Rundek, T
  • Saba, L
  • Schlachetzki, F
  • Silvestrini, M
  • Spinelli, F
  • Stilo, F
  • Sultan, S
  • Suri, JS
  • Svetlikov, A
  • Zeebregts, CJ
  • Chaturvedi, S

Unidades de investigação

Abstract

Despite the publication of several national/international guidelines, the optimal management of patients with asymptomatic carotid stenosis (AsxCS) remains controversial. This article compares 3 recently released guidelines (the 2020 German-Austrian, the 2021 European Stroke Organization [ESO], and the 2021 Society for Vascular Surgery [SVS] guidelines) vs the 2017 European Society for Vascular Surgery (ESVS) guidelines regarding the optimal management of AsxCS patients. The 2017 ESVS guidelines defined specific imaging/clinical parameters that may identify patient subgroups at high future stroke risk and recommended that carotid endarterectomy (CEA) should or carotid artery stenting (CAS) may be considered for these individuals. The 2020 German-Austrian guidelines provided similar recommendations with the 2017 ESVS Guidelines. The 2021 ESO Guidelines also recommended CEA for AsxCS patients at high risk for stroke on best medical treatment (BMT), but recommended against routine use of CAS in these patients. Finally, the SVS guidelines provided a strong recommendation for CEA+BMT vs BMT alone for low-surgical risk patients with >70% AsxCS. Thus, the ESVS, German-Austrian, and ESO guidelines concurred that all AsxCS patients should receive risk factor modification and BMT, but CEA should or CAS may also be considered for certain AsxCS patient subgroups at high risk for future ipsilateral ischemic stroke.

Dados da publicação

ISSN/ISSNe:
0003-3197, 1940-1574

Angiology  SAGE Publications Inc.

Tipo:
Review
Páginas:
903-910
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 4

Citações Recebidas na Scopus: 9

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • asymptomatic carotid stenosis; best medical treatment; stroke; carotid endarterectomy; carotid artery stenting; guidelines

Campos de estudo

Proyectos asociados

Endovascular Treatment of Aortic Arch Aneurysms

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico (Aneurysms) . 2020

The role of infrared thermography in predicting diabetic foot outcomes

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico (diabetic foot) . 2021

Endovascular solutions for type IA endoleak after endovascular aneurysm repair

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico . 2021

Intermittent Claudication: Importance of Supervised Exercise Programme

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação